<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="openVirus\examples\priya950\4-part\PMC7192973\results\search\disease\results.xml">
  <result pre=": Original Article Erucic acid from Isatis indigotica Fort. suppresses" exact="influenza" post="A virus replication and inflammation in vitro and in"/>
  <result pre="Isatis indigotica Fort. (Ban-Lan-Gen) is an herbal medicine prescribed for" exact="influenza" post="treatment. However, its active components and mode of action"/>
  <result pre="from Isatis indigotica Fort., and subsequently its underlying mechanism against" exact="influenza" post="A virus (IAV) infection was investigated in vitro and"/>
  <result pre="antiviral drugs such as oseltamivir are efficient approaches for controlling" exact="influenza" post="symptoms, but numerous studies reported that they are insufficiency"/>
  <result pre="required to identify novel agents that may effectively fight future" exact="influenza" post="pandemics. To date, the expanding understanding of the pathogenesis"/>
  <result pre="pandemics. To date, the expanding understanding of the pathogenesis of" exact="influenza" post="virus infections provided direction for the development of effective"/>
  <result pre="has elucidated their function and virulence in the pathogenicity of" exact="influenza" post="diseases. For instance, recombinant viruses carrying PB2 segments from"/>
  <result pre="therapeutic benefits but is ineffective in critically ill patients with" exact="influenza" post="virus infection [7]. Excessive inflammation triggered by viruses is"/>
  <result pre="of cytokines was found in humans and ferrets with seasonal" exact="influenza" post="virus infections [8,9]. Intense pro-inflammatory responses were observed in"/>
  <result pre="factors and the host immune response are important contributors of" exact="influenza" post="diseases. Indeed, combination of antiviral agents with immunomodulators has"/>
  <result pre="agents with immunomodulators has been shown to effectively reduce lethal" exact="influenza" post="virus-induced morbidity and mortality as a proof of principle"/>
  <result pre="mortality as a proof of principle [12,13]. The replication of" exact="influenza" post="virus in host cells is dependent on a variety"/>
  <result pre="NF-κB signaling plays a critical role in productive replication of" exact="influenza" post="viruses. Cell lines with decreased NF-κB activities result in"/>
  <result pre="lines with decreased NF-κB activities result in decreased susceptibility to" exact="influenza" post="virus propagation [14]. Several studies revealed that influenza virus"/>
  <result pre="susceptibility to influenza virus propagation [14]. Several studies revealed that" exact="influenza" post="virus affects NF-κB signaling to reduce viral (v) RNA"/>
  <result pre="responses, inhibition of NF-κB activation or its genetic deficiency suppresses" exact="influenza" post="virus-mediated robust production of inflammatory mediators, such as interleukin"/>
  <result pre="[17]. Strikingly, administration of NF-κB inhibitors protects mice against lethal" exact="influenza" post="virus infection [18]. Additionally, activation of p38 kinase, a"/>
  <result pre="and levels of dysregulated cytokines [23]. The severity of seasonal" exact="influenza" post="virus infection in patients is associated with p38 kinase-mediated"/>
  <result pre="excessive pro-inflammatory responses, and may be promising therapeutic interventions in" exact="influenza" post="diseases. Isatis indigotica Fort. belongs to the plant family"/>
  <result pre="may be of interest in the development of drugs for" exact="influenza" post="disease intervention. Among these active components, the monounsaturated fatty"/>
  <result pre="pathway [31]. However, potential beneficial properties of erucic acid against" exact="influenza" post="have not yet been reported. In the present study,"/>
  <result pre="we hypothesized that erucic acid exerts a protective effect against" exact="influenza" post="diseases and the underlying mechanism of anti-viral properties and"/>
  <result pre="influenza diseases and the underlying mechanism of anti-viral properties and" exact="suppression" post="of virus-mediated pro-inflammatory responses was investigated. 2 Materials and"/>
  <result pre="Antiviral activity assays The antiviral activity of erucic acid against" exact="influenza" post="viruses was evaluated in MDCK cells. Monolayers of MDCK"/>
  <result pre="of the 50% tissue culture infectious dose (100 × TCID50) of the" exact="influenza" post="virus strains including A/PR/8/34 (H1N1), A/GZ/GIRD07/09 (H1N1), A/HK/8/68 (H3N2),"/>
  <result pre="Microsystems GmbH, Wetzlar, Germany). The 50% inhibitory concentration (IC50) for" exact="influenza" post="virus inhibition by the compounds was determined using the"/>
  <result pre="to IC50. MDCK cells in 6-well plates were infected with" exact="influenza" post="viruses (100 PFU/well) and incubated with the indicated concentration of"/>
  <result pre="(6 × 105 cells/well) grown in 6-well plates were inoculated with 100 PFU/well indicated" exact="influenza" post="virus diluted in serum-free DMEM and incubated at 37 °C"/>
  <result pre="Mice were randomly divided into five groups: Control group (non-infected);" exact="influenza" post="virus-infected group; erucic acid high dose treatment groups, erucic"/>
  <result pre="isoflurane and inoculated intranasally with 5 LD50 of mouse-adapted A/FM/1/47(H1N1)" exact="influenza" post="virus. 2.7 Lung histopathology and immunohistochemical staining At day"/>
  <result pre="2000 (Invitrogen) for 6 h. Subsequently, transfected cells were stimulated with" exact="influenza" post="virus (MOI = 0.1) or IFN-β (500 ng/mL) in the presence or"/>
  <result pre="assays, 293 cells stably expressing pNF-κB-TATA-F-Luc and pQCXIP-eGFP were infected with" exact="influenza" post="virus (MOI = 0.1) in the presence or absence of erucic"/>
  <result pre="was performed to study the efficacy of erucic acid against" exact="influenza" post="A viruses. Our results showed that erucic acid treatment"/>
  <result pre="significantly reduced the CPE in MDCK cells induced by five" exact="influenza" post="virus strains, including A/PR/8/34 (H1N1), A/GZ/GIRD07/09 (H1N1), A/HK/8/68 (H3N2),"/>
  <result pre="transcription activity. Table 1 Antiviral activity of erucic acid against" exact="influenza" post="viruses. [alt-text] Table 1 Virus strain Erucic acid Oseltamivir"/>
  <result pre="formation in MDCK cells. Monolayers of MDCK were inoculated with" exact="influenza" post="virus (A/PR/8/34 [H1N1], A/GZ/GIRD07/09 [H1N1], A/HK/8/68 [H3N2], A/HK/Y280/97 [H9N2]"/>
  <result pre="the production of progeny viruses. MDCK cells were infected with" exact="influenza" post="virus (A/PR/8/34 [H1N1], A/GZ/GIRD07/09 [H1N1], A/HK/8/68 [H3N2], A/HK/Y280/97 [H9N2]"/>
  <result pre="and JNK), NF-κB and AKT signaling pathways were activated by" exact="influenza" post="A virus infection. Moreover, we observed that the activation"/>
  <result pre="by aberrant signaling contributes to the severity and mortality of" exact="influenza" post="diseases [35]. Since erucic acid suppressed activation of p38"/>
  <result pre="using Luminex assays. The cytokine profile revealed that infection with" exact="influenza" post="A virus resulted in a significant elevation of an"/>
  <result pre="and NF-κB signaling [36,37], were associated with the pathogenesis of" exact="influenza" post="infection. Therefore, we suggested that erucic acid may decrease"/>
  <result pre="pro-inflammatory mediators, lung damage is worsened by apoptosis induction during" exact="influenza" post="virus infection [38]. In this regard, the effect of"/>
  <result pre="[38]. In this regard, the effect of erucic acid on" exact="influenza" post="virus-induced apoptosis in A549 cells was determined. Annexin V staining"/>
  <result pre="blot analysis of expression of cleaved caspase-3 and PARP in" exact="influenza" post="virus-infected cells (Fig. 5B). It is well established that"/>
  <result pre="and p38 MAPK inhibitor SB203580 (column 6) treatment resulted in" exact="suppression" post="of type I INF (IFN-β) and III INF (IFN-λ1)"/>
  <result pre="(Fig. 6A, column 7 and 9). This indicated that IFN" exact="suppression" post="effects by erucic acid were potentially associated with NF-κB"/>
  <result pre="analysis of pro-inflammatory cytokines secreted in IFN-pre-treated cells prior to" exact="influenza" post="A/PR8/34(H1N1) (MOI = 0.1) infection. A549 cells were pre-treated"/>
  <result pre="pre-treated with IFN-β (500 ng/mL) for 4 h, infected with" exact="influenza" post="A/PR8/34(H1N1) and treated with or without erucic acid. Data"/>
  <result pre="days prior to challenge with 5 LD50 of mouse-adapted H1N1" exact="influenza" post="strain (A/FM/1/47). On day 7 p.i., IAV-infected mice exhibited"/>
  <result pre="pro-inflammatory responses through inhibition of aberrant signaling cascades linked to" exact="influenza" post="severity. Fig. 8 Erucic acid attenuates excessive pulmonary inflammation"/>
  <result pre="vs. IAV-infected. 4 Discussion Seasonal epidemics and occasional pandemics of" exact="influenza" post="viruses constitute a serious public health risk and inflict"/>
  <result pre="immense morbidity and mortality. Antiviral drugs are used clinically in" exact="influenza" post="therapy; however, even early oseltamivir treatment does not improve"/>
  <result pre="uncontrollable cytokine storm [10,45]. Clinical evidence demonstrated an association of" exact="influenza" post="pathogenesis with the intensity of the inflammatory response, highlighting"/>
  <result pre="inflammatory response, highlighting the potential benefits of immunomodulatory agents for" exact="influenza" post="treatments. Nevertheless, given that viral PAMPs are detected by"/>
  <result pre="properties shows potential in the treatment of hypercytokinemia in severe" exact="influenza" post="cases. Antiviral activity further acts to reduce inflammation by"/>
  <result pre="Viral load is a critical contributor in the pathogenesis of" exact="influenza" post="diseases. Erucic acid presented efficiency against several strains of"/>
  <result pre="diseases. Erucic acid presented efficiency against several strains of human" exact="influenza" post="viruses, including A/PR/8/34 (H1N1), A/GZ/GIRD07/09 (H1N1), A/HK/8/68 (H3N2), A/HK/Y280/97"/>
  <result pre="this study, data revealed that erucic acid treatment suppressed the" exact="influenza" post="virus-mediated activation of NF-κB and p38 MAPK signaling in"/>
  <result pre="inhibitors (Fig. 3C). Therefore, it was proposed that inhibition of" exact="influenza" post="virus-mediated activation of the NF-κB and p38 MAPK signaling"/>
  <result pre="acute lung injury (ALI) or continues progress to form severe" exact="acute respiratory distress syndrome" post="(ARDS), which has been ascribed to the disordered inflammatory"/>
  <result pre="IL-6 are closely correlated with symptoms and fever in human" exact="influenza" post="infection [9,46]. Elevation of IL-17 and IP-10 was reported"/>
  <result pre="IP-10 was reported to mediate ALI during the 2009 pandemic" exact="influenza" post="A (H1N1) virus infection [47,48]. Development of ALI or"/>
  <result pre="activation of NF-κB and p38 kinase signaling is involved in" exact="influenza" post="virus-induced dysregulation of pro-inflammatory mediator production. NF-κB deficiency markedly"/>
  <result pre="[36,37]. Overexpression of COX-2 is implicated in the pathogenesis of" exact="avian influenza" post="H5N1 infections [54]. Expression of COX-2 is induced upon"/>
  <result pre="Overexpression of COX-2 is implicated in the pathogenesis of avian" exact="influenza" post="H5N1 infections [54]. Expression of COX-2 is induced upon"/>
  <result pre="effects via inhibition of NF-κB and p38 kinase signaling during" exact="influenza" post="virus infection. Erucic acid treatment was also found to"/>
  <result pre="exhibit increased susceptibility to various types of viral infection, including" exact="vaccinia virus" post="[61], coxsackievirus B3 [62], Friend retrovirus [63] and influenza"/>
  <result pre="vaccinia virus [61], coxsackievirus B3 [62], Friend retrovirus [63] and" exact="influenza" post="virus [64]. However, given immunomodulatory properties of IFNs, the"/>
  <result pre="to the IFN-mediated amplification of a detrimental pro-inflammatory response to" exact="influenza" post="virus infection. In vitro data suggested that an increasing"/>
  <result pre="data suggested that an increasing percentage of apoptotic cells following" exact="influenza" post="virus infection and vRNA stimulation was decreased upon erucic"/>
  <result pre="to eliminate invading pathogens. However, an increasing evidence suggests that" exact="influenza" post="progression has a direct link to the apoptosis of"/>
  <result pre="CD8+ T lymphocytes are more abundant in patients with severe" exact="pneumonia" post="than moderate pneumonia [72]. Histological findings of the lungs"/>
  <result pre="are more abundant in patients with severe pneumonia than moderate" exact="pneumonia" post="[72]. Histological findings of the lungs of novel swine"/>
  <result pre="In conclusion, it was revealed that erucic acid treatment of" exact="influenza" post="virus-infected cells resulted in the significant suppression of viral"/>
  <result pre="acid treatment of influenza virus-infected cells resulted in the significant" exact="suppression" post="of viral propagation and pro-inflammatory mediator production via NF-κB"/>
  <result pre="in IFN-β pre-treated cells. Moreover, erucic acid protected mice from" exact="influenza" post="virus-induced lung injury and improved mortality by attenuating viral"/>
  <result pre="pro-inflammatory responses that may have potential in the treatment of" exact="influenza" post="illness. Conflicts of interest The authors declare that there"/>
  <result pre="References 1JohnsonN.P.MuellerJ.Updating the accounts: global mortality of the 1918-1920 &quot;Spanish&quot;" exact="influenza" post="pandemicBull. Hist. Med.76200210511511875246 2GaoH.N.LuH.Z.CaoB.Clinical findings in 111 cases of"/>
  <result pre="influenza pandemicBull. Hist. Med.76200210511511875246 2GaoH.N.LuH.Z.CaoB.Clinical findings in 111 cases of" exact="influenza" post="A (H7N9) virus infectionN. Engl. J. Med.36820132277228523697469 3ToK.K.W.NgK.H.L.QueT.-L.Avian influenza"/>
  <result pre="of influenza A (H7N9) virus infectionN. Engl. J. Med.36820132277228523697469 3ToK.K.W.NgK.H.L.QueT.-L.Avian" exact="influenza" post="A H5N1 virus: a continuous threat to humansEmerg. Microb."/>
  <result pre="Infect.12012e25 4BianJ.-R.Clinical aspects and cytokine response in adults with seasonal" exact="influenza" post="infectionInt. J. Clin. Exp. Med.720145593560225664078 5ZamarinD.Garcia-SastreA.XiaoX.Influenza virus PB1-F2 protein"/>
  <result pre="cell death through mitochondrial ANT3 and VDAC1PLoS Pathog.12005e416201016 6ForeroA.Tisoncik-GoJ.WatanabeT.The 1918" exact="influenza" post="virus PB2 protein enhances virulence through the disruption of"/>
  <result pre="late oseltamivir treatment in severely ill patients with 2009 pandemic" exact="influenza" post="A (H1N1): speed is lifeJ. Antimicrob. Chemother.66201195996321406435 8SvitekN.RuddP.A.ObojesK.Severe seasonal"/>
  <result pre="influenza A (H1N1): speed is lifeJ. Antimicrob. Chemother.66201195996321406435 8SvitekN.RuddP.A.ObojesK.Severe seasonal" exact="influenza" post="in ferrets correlates with reduced interferon and increased IL-6"/>
  <result pre="inductionVirology3762008535918420248 9GentileD.DoyleW.WhitesideT.Increased interleukin-6 levels in nasal lavage samples following experimental" exact="influenza" post="A virus infectionClin. Diagn. Lab. Immunol.519986046089729523 10De JongM.D.SimmonsC.P.ThanhT.T.Fatal outcome"/>
  <result pre="virus infectionClin. Diagn. Lab. Immunol.519986046089729523 10De JongM.D.SimmonsC.P.ThanhT.T.Fatal outcome of human" exact="influenza" post="A (H5N1) is associated with high viral load and"/>
  <result pre="of the cytokine response does not protect against lethal H5N1" exact="influenza" post="infectionProc. Natl. Acad. Sci. U.S.A.1042007124791248117640882 12ZhengB.J.ChanK.W.LinY.P.Delayed antiviral plus immunomodulator"/>
  <result pre="still reduces mortality in mice infected by high inoculum of" exact="influenza" post="A/H5N1 virusProc. Natl. Acad. Sci. U.S.A.10520088091809618523003 13SharmaG.Champalal SharmaD.Hwei FenL.Reduction"/>
  <result pre="A/H5N1 virusProc. Natl. Acad. Sci. U.S.A.10520088091809618523003 13SharmaG.Champalal SharmaD.Hwei FenL.Reduction of" exact="influenza" post="virus-induced lung inflammation and mortality in animals treated with"/>
  <result pre="inhibitorEmerg. Microbes Infect.22013e5426038487 14NimmerjahnF.DudziakD.DirmeierU.Active NF-kappaB signalling is a prerequisite for" exact="influenza" post="virus infectionJ. Gen. Virol.8520042347235615269376 15KumarN.XinZ.T.LiangY.NF-kappaB signaling differentially regulates influenza"/>
  <result pre="for influenza virus infectionJ. Gen. Virol.8520042347235615269376 15KumarN.XinZ.T.LiangY.NF-kappaB signaling differentially regulates" exact="influenza" post="virus RNA synthesisJ. Virol.8220089880988918701591 16PintoR.HeroldS.CakarovaL.Inhibition of influenza virus-induced NF-kappaB"/>
  <result pre="signaling differentially regulates influenza virus RNA synthesisJ. Virol.8220089880988918701591 16PintoR.HeroldS.CakarovaL.Inhibition of" exact="influenza" post="virus-induced NF-kappaB and Raf/MEK/ERK activation can reduce both virus"/>
  <result pre="Res.922011455621641936 17DroebnerK.ReilingS.J.PlanzO.Role of hypercytokinemia in NF-kappaB p50-deficient mice after H5N1" exact="influenza" post="A virus infectionJ. Virol.822008114611146618768968 18MazurI.WurzerW.J.EhrhardtC.Acetylsalicylic acid (ASA) blocks influenza"/>
  <result pre="H5N1 influenza A virus infectionJ. Virol.822008114611146618768968 18MazurI.WurzerW.J.EhrhardtC.Acetylsalicylic acid (ASA) blocks" exact="influenza" post="virus propagation via its NF-kappaB-inhibiting activityCell Microbiol.920071683169417324159 19MarchantD.SingheraG.K.UtokaparchS.Toll-like receptor"/>
  <result pre="20NencioniL.De ChiaraG.SgarbantiR.Bcl-2 expression and p38MAPK activity in cells infected with" exact="influenza" post="A virus: impact on virally induced apoptosis and viral"/>
  <result pre="Chem.2842009160041601519336399 21HuiK.P.Y.LeeS.M.Y.CheungC.y.Induction of proinflammatory cytokines in primary human macrophages by" exact="influenza" post="A virus (H5N1) is selectively regulated by IFN regulatory"/>
  <result pre="mitogen-activated protein kinase and c-jun-NH2-terminal kinase regulate RANTES production by" exact="influenza" post="virus-infected human bronchial epithelial cellsJ. Immunol.16420003222322810706714 23BorgelingY.SchmolkeM.ViemannD.Inhibition of p38"/>
  <result pre="epithelial cellsJ. Immunol.16420003222322810706714 23BorgelingY.SchmolkeM.ViemannD.Inhibition of p38 mitogen-activated protein kinase impairs" exact="influenza" post="virus-induced primary and secondary host gene responses and protects"/>
  <result pre="and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human" exact="influenza" post="A virus infectionClin. Infect. Dis.45200772373117712756 25LiZ.ZhaoJ.ZhouH.Cappariloside A shows antiviral"/>
  <result pre="Dis.45200772373117712756 25LiZ.ZhaoJ.ZhouH.Cappariloside A shows antiviral and better anti-inflammatory effects against" exact="influenza" post="virus via regulating host IFN signaling, in vitro and"/>
  <result pre="in vivo and in vitroFront. Pharmacol.1020197830792656 27LiZ.LiL.ZhouH.Radix isatidis polysaccharides inhibit" exact="influenza" post="a virus and influenza A virus-induced inflammation via suppression"/>
  <result pre="vitroFront. Pharmacol.1020197830792656 27LiZ.LiL.ZhouH.Radix isatidis polysaccharides inhibit influenza a virus and" exact="influenza" post="A virus-induced inflammation via suppression of host TLR3 signaling"/>
  <result pre="inhibit influenza a virus and influenza A virus-induced inflammation via" exact="suppression" post="of host TLR3 signaling in vitroMolecules222017 28YangZ.WangY.ZhengZ.Antiviral activity of"/>
  <result pre="activity of Isatis indigotica root-derived clemastanin B against human and" exact="avian influenza" post="A and B viruses in vitroInt. J. Mol. Med.31201386787323403777"/>
  <result pre="of Isatis indigotica root-derived clemastanin B against human and avian" exact="influenza" post="A and B viruses in vitroInt. J. Mol. Med.31201386787323403777"/>
  <result pre="Mol. Med.31201386787323403777 29LiJ.ZhouB.LiC.Lariciresinol-4-O-beta-D-glucopyranoside from the root of Isatis indigotica inhibits" exact="influenza" post="A virus-induced pro-inflammatory responseJ. Ethnopharmacol.174201537938626320688 30ZhouB.LiJ.LiangX.Transcriptome profiling of influenza"/>
  <result pre="inhibits influenza A virus-induced pro-inflammatory responseJ. Ethnopharmacol.174201537938626320688 30ZhouB.LiJ.LiangX.Transcriptome profiling of" exact="influenza" post="A virus-infected lung epithelial (A549) cells with lariciresinol-4-beta-D-glucopyranoside treatmentPLoS"/>
  <result pre="anti-viral effects via inhibition of the NF-kappaB signaling pathway in" exact="influenza" post="A virus-infected cellsJ. Ethnopharmacol.2017 34LudwigS.Targeting cell signalling pathways to"/>
  <result pre="anti-influenza therapyJ. Antimicrob. Chemother.6420091419420020 35RamosI.Fernandez-SesmaA.Modulating the innate immune response to" exact="influenza" post="A virus: potential therapeutic use of anti-inflammatory drugsFront. Immunol.62015"/>
  <result pre="IFN-β contributes to apoptotic alveolar epithelial cell injury in severe" exact="influenza" post="virus pneumoniaPLoS Pathog.92013e1003188 39BeschR.PoeckH.HohenauerT.Proapoptotic signaling induced by RIG-I and"/>
  <result pre="in human melanoma cellsJ. Clin. Investig.11920092399241119620789 40RossmanJ.S.LambR.A.Autophagy, apoptosis, and the" exact="influenza" post="virus M2 proteinCell Host Microbe6200929930019837369 41ZhangC.YangY.ZhouX.The NS1 protein of"/>
  <result pre="influenza virus M2 proteinCell Host Microbe6200929930019837369 41ZhangC.YangY.ZhouX.The NS1 protein of" exact="influenza" post="A virus interacts with heat shock protein Hsp90 in"/>
  <result pre="mechanismJ. Biol. Chem.28220077576758117204473 44DavidsonS.CrottaS.McCabeT.M.Pathogenic potential of interferon αβ in acute" exact="influenza" post="infectionNat. Commun.52014386424844667 45ChiY.ZhuY.WenT.Cytokine and chemokine levels in patients infected"/>
  <result pre="45ChiY.ZhuY.WenT.Cytokine and chemokine levels in patients infected with the novel" exact="avian influenza" post="A (H7N9) virus in ChinaJ. Infect. Dis.20820131962196723990573 46KaiserL.FritzR.S.StrausS.E.Symptom pathogenesis"/>
  <result pre="and chemokine levels in patients infected with the novel avian" exact="influenza" post="A (H7N9) virus in ChinaJ. Infect. Dis.20820131962196723990573 46KaiserL.FritzR.S.StrausS.E.Symptom pathogenesis"/>
  <result pre="other cytokine responsesJ. Med. Virol.64200126226811424113 47WangW.YangP.ZhongY.Monoclonal antibody against CXCL-10/IP-10 ameliorates" exact="influenza" post="A (H1N1) virus induced acute lung injuryCell Res.23201357758023419516 48LiC.YangP.SunY.IL-17"/>
  <result pre="response mediates acute lung injury induced by the 2009 pandemic" exact="influenza" post="A (H1N1) virusCell Res.22201252853822025253 49MullinJ.M.SnockK.V.Effect of tumor necrosis factor"/>
  <result pre="hyperinduction of tumor necrosis factor alpha expression in response to" exact="avian influenza" post="virus H5N1J. Virol.792005101471015416051807 54LeeS.M.CheungC.Y.NichollsJ.M.Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a"/>
  <result pre="of tumor necrosis factor alpha expression in response to avian" exact="influenza" post="virus H5N1J. Virol.792005101471015416051807 54LeeS.M.CheungC.Y.NichollsJ.M.Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a"/>
  <result pre="of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of" exact="avian influenza" post="H5N1 infectionJ. Infect. Dis.198200852553518613795 55KirkbyN.S.ZaissA.K.WrightW.R.Differential COX-2 induction by viral"/>
  <result pre="cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian" exact="influenza" post="H5N1 infectionJ. Infect. Dis.198200852553518613795 55KirkbyN.S.ZaissA.K.WrightW.R.Differential COX-2 induction by viral"/>
  <result pre="cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to" exact="influenza" post="A viral infectionJ. Immunol.17520056878688416272346 58CareyM.A.BradburyJ.A.RebollosoY.D.Pharmacologic inhibition of COX-1 and"/>
  <result pre="viral infectionJ. Immunol.17520056878688416272346 58CareyM.A.BradburyJ.A.RebollosoY.D.Pharmacologic inhibition of COX-1 and COX-2 in" exact="influenza" post="A viral infection in micePLoS One52010e11610 59CoulombeF.JaworskaJ.VerwayM.Targeted prostaglandin E2"/>
  <result pre="Virol.8020063438344416537611 64KoernerI.KochsG.KalinkeU.Protective role of beta interferon in host defense against" exact="influenza" post="A virusJ. Virol.8120072025203017151098 65GoritzkaM.DurantL.R.PereiraC.Alpha/beta interferon receptor signaling amplifies early"/>
  <result pre="ultrastructural analysis of surgical lung biopsies in patients with swine-origin" exact="influenza" post="type A/H1N1 and acute respiratory failureClinics (Sao Paulo)6520101229123721340209 69UiprasertkulM.KitphatiR.PuthavathanaP.Apoptosis"/>
  <result pre="and acute respiratory failureClinics (Sao Paulo)6520101229123721340209 69UiprasertkulM.KitphatiR.PuthavathanaP.Apoptosis and pathogenesis of" exact="avian influenza" post="A (H5N1) virus in humansEmerg. Infect. Dis.13200770871217553248 70IshikawaE.NakazawaM.YoshinariM.Role of"/>
  <result pre="acute respiratory failureClinics (Sao Paulo)6520101229123721340209 69UiprasertkulM.KitphatiR.PuthavathanaP.Apoptosis and pathogenesis of avian" exact="influenza" post="A (H5N1) virus in humansEmerg. Infect. Dis.13200770871217553248 70IshikawaE.NakazawaM.YoshinariM.Role of"/>
  <result pre="of tumor necrosis factor-related apoptosis-inducing ligand in immune response to" exact="influenza" post="virus infection in miceJ. Virol.7920057658766315919918 71KohlmeierJ.E.CookenhamT.RobertsA.D.Type I interferons regulate"/>
  <result pre="72KimJ.E.BauerS.LaK.S.CD4+/CD8+ T lymphocytes imbalance in children with severe 2009 pandemic" exact="influenza" post="A (H1N1) pneumoniaKorean J. Pediatr.54201120721121829412 73MauadT.HajjarL.A.CallegariG.D.Lung pathology in fatal"/>
  <result pre="(H1N1) pneumoniaKorean J. Pediatr.54201120721121829412 73MauadT.HajjarL.A.CallegariG.D.Lung pathology in fatal novel human" exact="influenza" post="A (H1N1) infectionAm. J. Respir. Crit. Care Med.1812010727919875682 74EnelowR.I.MohammedA.Z.StolerM.H.Structural"/>
  <result pre="de SandtC.E.BarcenaM.KosterA.J.Human CD8(+) T cells damage noninfected epithelial cells during" exact="influenza" post="virus infection in vitroAm. J. Respir. Cell Mol. Biol.57201753654628613916"/>
 </snippets>
</snippetsTree>
